Publications: Stephen Ezell
April 22, 2024
LATAM Health Champions, 2024
Innovation plays a critical role in improving public health and in overcoming global health challenges. The call for LATAM Health Champions, which ran from February 5 to March 5, 2024, received more than 60 applications proposing innovative health solutions to a wide range of health challenges. Here, the top 20 are highlighted.
February 14, 2024
Assessing India’s Readiness to Assume a Greater Role in Global Semiconductor Value Chains
India has the potential to play a much more significant role in global semiconductor value chains, provided the government upholds its investment policies, maintains a conducive regulatory and business environment, and avoids measures that create unpredictability.
February 6, 2024
Comments to the NIST Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights
America’s innovation system is fragile, and its leadership in advanced technology industries is never guaranteed or assured. The United States has taken—only to sacrifice—its lead in a wide-range of advanced technology industries, often in part because of significant policy lapses. It’s no time for additional unforced errors.
February 1, 2024
The CHIPS Program Office Needs to Think Like Economic Developers, Not Bankers
Accelerating the construction of semiconductor facilities requires thinking in terms of “let’s get it done,” not “let’s cover every base and limit every liability.”
January 31, 2024
Comments to the U.S. Department of Health and Human Services Regarding the WHO Pandemic Preparedness Agreement
The United States should not endorse an IPR waiver in the WHO Pandemic Preparedness Agreement. It would not increase the number of vaccines or therapeutics, or the global supply that might be needed to address a future global pandemic.
January 29, 2024
Assessing the Dominican Republic’s Readiness to Play a Greater Role in Global Semiconductor and PCB Value Chains
The Dominican Republic is one of the world’s fastest-growing economies, offers perhaps the most attractive business environment in Latin America, and is a leading candidate for nearshored investments in advanced manufacturing activity—particularly for electronics such as printed circuit boards (PCBs) and the assembly, test, and packaging (ATP) of semiconductors.
December 11, 2023
Biden’s Assertion of Excessive Biopharma Industry Concentration Is a Flawed Rationale for a Flawed Policy
The administration is flat wrong that America’s biopharmaceutical industry is excessively concentrated. It’s also flat wrong that U.S. drug prices are rising out of control.
November 13, 2023
Comments to the European Commission Regarding the EU General Pharmaceuticals Legislation
Changes proposed in the EU General Pharmaceutical Legislation would double down on policies that hinder, not enable, EU life-sciences innovation potential, while forsaking other avenues that could more effectively enhance access without compromising innovation.
September 14, 2023
Latin American Subnational Innovation Competitiveness Index
For policymakers to bolster the global competitiveness of their nations and regions, they first must know where they stand. This report benchmarks the 182 regions of Brazil, Chile, Colombia, Mexico, Peru, and the United States using 13 commonly available indicators of strength in the knowledge economy, in globalization, and in innovation capacity.
September 14, 2023
Transatlantic Subnational Innovation Competitiveness Index 2.0
For policymakers to bolster the global competitiveness of their nations and regions, they first must know where they stand. This report benchmarks the 121 regions of Austria, Germany, Hungary, Italy, Poland, Sweden, and the United States using 13 commonly available indicators of strength in the knowledge economy, globalization, and innovation capacity.